ArticleThoracic cancer2021

High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer.

Hui-Bo Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.